Opportunity Information: Apply for RFA CA 12 011
Apply for RFA CA 12 011
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "NCI National Clinical Trials Network Network Group Statistics and Data Management Centers (U10)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research.
- This funding opportunity was created on Jul 23, 2012 and posted on Jul 23, 2012.
- Applicants must submit their applications by Jan 15, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $35,000,000.00 to eligible and selected applicants.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NCI National Clinical Trials Network (NCTN) Network Group Statistics and Data Management Centers (U10) opportunity (Funding Opportunity Number RFA-CA-12-011) is a National Institutes of Health cooperative agreement designed to fund the statistical, data coordination, and trial data management backbone for the NCTN. In practical terms, it supports institutions that can serve as centralized centers responsible for the design-support, statistical leadership, data capture systems, data quality oversight, and analysis infrastructure needed to run large, multi-institution cancer clinical trials. The NCTN itself is intended to deliver state-of-the-art cancer treatment and advanced imaging clinical trials, with a particular emphasis on large, definitive studies that evaluate new therapies and related clinical approaches for both adult and pediatric populations. Because these trials often involve many hospitals and research sites, the program places heavy weight on strong, standardized data systems and rigorous statistical methods so that results are reliable, comparable across sites, and suitable for informing clinical practice.
This FOA focuses specifically on one of six coordinated components that together make up the NCTN. While the overall network includes Network Group Operations Centers, Statistics and Data Management Centers (the focus here), Integrated Translational Science Centers, Lead Academic Participating Site Centers, Network Radiotherapy and Imaging Core Services Centers, and a Canadian Collaborating Clinical Trials Network, this particular award targets the group that ensures the trials are statistically sound and operationally supported through robust data management. The expectation is that funded centers will enable complex multi-site trials to function smoothly by handling core tasks such as managing clinical trial databases, coordinating data submissions from participating sites, ensuring data integrity and timeliness, supporting protocol development from a statistical perspective, planning analyses, and producing high-quality trial reports and final analyses. Because the funding instrument is a cooperative agreement (U10), awardees should also expect substantial NIH/NCI involvement, meaning the work is carried out in close collaboration with the agency rather than as a fully independent investigator-driven grant.
Administratively, the opportunity is categorized as discretionary funding and falls under the NIH activity areas of education and health, aligned with CFDA numbers 93.394 (Cancer Detection and Diagnosis Research) and 93.395 (Cancer Treatment Research). The total estimated funding listed for the announcement is 35,000,000, and it explicitly states there is no cost-sharing or matching requirement, which matters for applicants budgeting for staff, systems, and operational capacity. The announcement was posted and created on July 23, 2012, with an original and current closing date of January 15, 2013, and an archive date of February 15, 2013, indicating the window for application under this specific FOA has passed, though similar NCI network opportunities may appear under later reissued announcements.
Eligibility is broad across U.S.-based organizations capable of supporting national-scale clinical trials infrastructure. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, for-profit organizations other than small businesses, nonprofit organizations (including those with and without 501(c)(3) status) other than institutions of higher education, and certain specialized institution types called out under “Other Eligible Applicants.” These include Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and regional organizations. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible; however, “foreign components” as defined by the NIH Grants Policy Statement are allowed, which typically means limited, well-justified elements of the work may involve foreign collaboration under NIH rules even though the primary applicant organization must be domestic.
Overall, the purpose of this grant opportunity is to ensure that the NCTN can run the kind of large, practice-changing cancer trials it was created to deliver by funding centers that specialize in statistics and data management at scale. These centers are essential for maintaining consistent data standards across many clinical sites, supporting advanced trial designs and imaging-related endpoints, and producing analyses that regulators, clinicians, and guideline committees can trust. The full announcement and requirements were provided through the NIH grants portal link associated with RFA-CA-12-011, and technical access issues were directed to the NIH Office of Extramural Research (OER) webmaster contacts listed in the notice.
FAQs: NCI National Clinical Trials Network (NCTN) Network Group Statistics and Data Management Centers (U10) - RFA-CA-12-011
What is this funding opportunity?
This opportunity is the NCI National Clinical Trials Network (NCTN) Network Group Statistics and Data Management Centers (U10) program under Funding Opportunity Number (FOA) RFA-CA-12-011. It is a National Institutes of Health (NIH) cooperative agreement intended to fund the statistical leadership, data coordination, and trial data management backbone needed to run large, multi-institution cancer clinical trials within the NCTN.
Which NIH institute is sponsoring this FOA?
The opportunity is sponsored by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH).
What does a "U10 cooperative agreement" mean in practice?
The award uses a cooperative agreement mechanism (U10), which indicates substantial NIH/NCI involvement. In practical terms, the work is expected to be carried out in close collaboration with NIH/NCI rather than as a fully independent, investigator-driven grant.
What is the main purpose of these Statistics and Data Management Centers?
The purpose is to ensure NCTN trials are statistically sound and operationally supported through robust, standardized data management. Funded centers serve as centralized hubs that support trial design from a statistical perspective, operate data capture systems, oversee data quality and timeliness, and provide analysis infrastructure and reporting for large, multi-site cancer clinical trials.
What kinds of clinical trials does the NCTN focus on?
The NCTN is intended to deliver state-of-the-art cancer treatment and advanced imaging clinical trials, with particular emphasis on large, definitive studies evaluating new therapies and related clinical approaches for both adult and pediatric populations.
Why is strong data management emphasized for this program?
NCTN trials often involve many hospitals and research sites. The program places heavy weight on strong, standardized data systems and rigorous statistical methods so that results are reliable, comparable across sites, and suitable for informing clinical practice.
What role does this FOA play within the broader NCTN structure?
This FOA focuses on one of six coordinated components that together make up the NCTN: the Network Group Statistics and Data Management Centers. Other NCTN components include Network Group Operations Centers, Integrated Translational Science Centers, Lead Academic Participating Site Centers, Network Radiotherapy and Imaging Core Services Centers, and a Canadian Collaborating Clinical Trials Network.
What specific activities are these centers expected to support?
Based on the description provided, expected core activities include managing clinical trial databases, coordinating data submissions from participating sites, ensuring data integrity and timeliness, supporting protocol development from a statistical perspective, planning analyses, and producing high-quality trial reports and final analyses.
Is this opportunity focused on operations support or research projects?
The described emphasis is on infrastructure and backbone capabilities for national-scale trials: statistical leadership, data coordination, data capture systems, data quality oversight, and analysis/reporting support that enable complex multi-site trials to function smoothly.
How much total funding is associated with this announcement?
The total estimated funding listed for the announcement is 35,000,000.
Is cost sharing or matching required?
No. The announcement explicitly states there is no cost-sharing or matching requirement.
What type of funding is this considered?
It is categorized as discretionary funding.
Which NIH activity areas and CFDA numbers are associated with this FOA?
The opportunity falls under NIH activity areas of education and health and is aligned with CFDA 93.394 (Cancer Detection and Diagnosis Research) and 93.395 (Cancer Treatment Research).
When was the opportunity posted and when did it close?
The announcement was posted and created on July 23, 2012. The original and current closing date listed is January 15, 2013, and the archive date is February 15, 2013.
Is the application window for RFA-CA-12-011 still open?
No. The closing date and archive date indicate that the application window for this specific FOA has passed.
Could similar opportunities appear again in the future?
The notice indicates that while this specific FOA is closed, similar NCI network opportunities may appear under later reissued announcements.
Who is eligible to apply?
Eligibility is broad across U.S.-based organizations capable of supporting national-scale clinical trials infrastructure. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, for-profit organizations other than small businesses, nonprofit organizations (including those with and without 501(c)(3) status) other than institutions of higher education, and other specialized eligible applicant types listed in the announcement.
Are minority-serving institutions included in eligible applicant types?
Yes. The FOA explicitly calls out eligibility for Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and regional organizations under "Other Eligible Applicants."
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible to apply.
Can a non-U.S. component of a U.S. organization apply?
No. Non-U.S. components of U.S. organizations are also not eligible to apply.
Are any foreign activities allowed at all?
Yes, limited foreign involvement may be possible because "foreign components" (as defined by the NIH Grants Policy Statement) are allowed. This generally means specific, well-justified elements of the work may involve foreign collaboration under NIH rules, while the primary applicant organization must be domestic.
What kinds of institutional capabilities are implied by this FOA?
The description implies applicants should be able to function as centralized centers with the staffing, systems, and operational capacity to provide statistical leadership, support protocol development, run clinical trial database and data capture systems, oversee data quality, coordinate data flows from many sites, and produce analyses and reports for large multi-institution trials.
Where was the full announcement made available?
The full announcement and requirements were provided through the NIH grants portal link associated with RFA-CA-12-011.
Who should be contacted for technical access issues related to the announcement?
Technical access issues were directed to the NIH Office of Extramural Research (OER) webmaster contacts listed in the notice.
Browse more opportunities from the same category: Education Health
Next opportunity: NCI National Clinical Trials Network Network Group Integrated Translational Science Centers (U10)
Previous opportunity: NCI National Clinical Trials Network Network Group Operations Centers (U10)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 12 011
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 12 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCI National Clinical Trials Network Network Group Integrated Translational Science Centers (U10) Apply for RFA CA 12 012 Funding Number: RFA CA 12 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI National Clinical Trials Network Network Lead Academic Participating Sites (U10) Apply for RFA CA 12 013 Funding Number: RFA CA 12 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Behavioral Science Track Award for Rapid Transition (B/START) (R03) Apply for PAR 12 251 Funding Number: PAR 12 251 Agency: National Institutes of Health Category: Education Health Funding Amount: $75,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44) Apply for RFA CA 12 023 Funding Number: RFA CA 12 023 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| The Interplay of Substance Abuse and HIV 1 Infection on Glial Cell Function (R01) Apply for RFA DA 13 010 Funding Number: RFA DA 13 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| The Interplay of Substance Abuse and HIV 1 Infection on Glial Cell Function (R21) Apply for RFA DA 13 011 Funding Number: RFA DA 13 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Examination of Survivorship Care Planning Efficacy and Impact R21 Apply for PA 12 274 Funding Number: PA 12 274 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Examination of Survivorship Care Planning Efficacy and Impact R01 Apply for PA 12 275 Funding Number: PA 12 275 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| FY 2013 American Schools and Hospitals Abroad Program Apply for DRAFT APS ASHA 12 000001 Funding Number: DRAFT APS ASHA 12 000001 Agency: Agency for International Development Category: Education Health Funding Amount: $2,000,000 |
| HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R21) Apply for PA 12 280 Funding Number: PA 12 280 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R01) Apply for PA 12 281 Funding Number: PA 12 281 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| AIDS Science Track Award for Research Transition (R03) Apply for PA 12 282 Funding Number: PA 12 282 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Revisions for Early Stage Development of Informatics Technology (R01) Apply for PAR 12 286 Funding Number: PAR 12 286 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Advanced Development of Informatics Technology (U24) Apply for PAR 12 287 Funding Number: PAR 12 287 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Early Stage Development of Informatics Technology (U01) Apply for PAR 12 288 Funding Number: PAR 12 288 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Revisions for Early Stage Development of Informatics Technology (U01) Apply for PAR 12 289 Funding Number: PAR 12 289 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revisions for Early Stage Development of Informatics Technology (P01) Apply for PAR 12 290 Funding Number: PAR 12 290 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Research Answers to NCIs Provocative Questions Group A (R01) Apply for RFA CA 12 015 Funding Number: RFA CA 12 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group A (R21) Apply for RFA CA 12 016 Funding Number: RFA CA 12 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group B (R01) Apply for RFA CA 12 017 Funding Number: RFA CA 12 017 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 12 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.